CELEBRATING its 1995 founding, Lush had a few tricks up its sleeve to dress up some of its classics during a Nov. 17 party in Makati’s Poblacion. Guests rolled up their sleeves to make their own cleansers and bath bombs. However, its signature holiday line, Snow Fairy, was there at the launch, in three new […]CELEBRATING its 1995 founding, Lush had a few tricks up its sleeve to dress up some of its classics during a Nov. 17 party in Makati’s Poblacion. Guests rolled up their sleeves to make their own cleansers and bath bombs. However, its signature holiday line, Snow Fairy, was there at the launch, in three new […]

30 years and a holiday collection

2025/12/08 00:03
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

CELEBRATING its 1995 founding, Lush had a few tricks up its sleeve to dress up some of its classics during a Nov. 17 party in Makati’s Poblacion.

Guests rolled up their sleeves to make their own cleansers and bath bombs. However, its signature holiday line, Snow Fairy, was there at the launch, in three new forms. Brand new additions to the 2025 Snow Fairy range include a pink edition of the Scrubbee exfoliator, a hair primer, and a miniature candle. The signature shower gels, soaps, lotions, and even bath clay were also on display. The bath bombs (a statement says UK staff handmade 11.5 million of them last year) include a raspberry one shaped like a unicorn, a citrusy penguin, and a date-scented reindeer.

As for its scents, it’s pushing the Turmeric Latte perfume (vanilla, milk, and tonka bean: gourmand scents seem to be on trend), and the Yog Nog body spray with clove bud oil and ylang-ylang. A signature, Karma, is now in a limited-edition bottle.

In 2026, Lush will release a new skincare line in its UK base, which will arrive in the Philippines a couple of months after, according to Liberty Nicholls, international partner support for Lush in an interview with BusinessWorld. While not sharing any details about the line’s composition, she said, “It’s about protecting your microbiome. The products use fresh active ingredients rather than synthetic active ingredients, which will look after the skin’s barrier.”

30 YEARS IN KIND BEAUTY
“I think what led to us being here, in this position, is the innovation, the sustainability, and the focus on the human part of the business. Really connecting with our staff, but also with our consumer base,” said Ms. Nicholls. A statement says they had sold 21.2 million items last year, through 850 shops in 50 countries.

Founded in 1995 by Mark Constantine, his wife Mo, and a handful of other partners, Lush was at the forefront of the natural beauty movement. In fact, prior to founding their own brand, Lush had once supplied to The Body Shop, another British natural beauty brand. With Lush’s product line being about 95% vegan, Ms. Nicholls noted that their zero animal testing policy then influenced that of The Body Shop. “We love the planet and we want it to be looking after us for as long as possible,” said Ms. Nicholls.

Asked if their natural and handmade approach — a form of corporate morality — influences quality, she said, “100% yes.”

She talked about their ethical sourcing for ingredients: from using synthetic mica (as glitter) to help reduce mining operations, to site visits to source vanilla and tonka beans. “We can see from the person supplying that ingredient the quality of life they’re having, and ensure that they’re getting a fair wage. Because we did that, from that moment, all the way through the supply chain, you feel that when you try it.

“I think when something’s handmade, with somebody’s hands, there’s love going into the products,” she said.

In the Philippines, Lush is exclusively distributed by Stores Specialists, Inc., and has shops at Alabang Town Center, Ayala Malls Manila Bay, Bonifacio High Street, Glorietta 4, Greenbelt 3, Robinsons Magnolia, Shangri-La Plaza, SM Mall of Asia, SM Megamall, and TriNoma. Lush is also available in Shopee, Lazada, Zalora, and Trunc.com. For more information visit www.lush.com.ph and www.ssilife.com.ph or follow @ssilifeph on Instagram. — Joseph L. Garcia

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09